China welcomes foreign firms to deepen investment cooperation: vice premier

Democrats Open Probe Into Trump’s Deal to Export Nvidia Chips to China notus.org

China eyes South China Sea control for Taiwan invasion: Japan think tank Japan Wire by Kyodo News

China has approved US pharmaceutical giant Eli Lilly’s weight-loss pill orforglipron, making it the country’s first available oral GLP-1 treatment for obesity as global drug makers seek to tap the country’s massive weight-management market. China’s National Medical Products Administration announced the approval on Thursday, saying that the once-daily pill, marketed as Foundayo, could be used for chronic weight management by obese or overweight adults. GLP-1 receptor agonists are synthetic...

No more needles: Eli Lilly wins China nod for first oral GLP-1 weight-loss drug South China Morning Post